Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |